These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 20227543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study.
    Harel Z, Wolter K, Gold MA, Cromer B, Bruner A, Stager M, Bachrach L, Hertweck P, Nelson A, Nelson D, Coupey S, Johnson CC, Burkman R, Bone H.
    J Pediatr Adolesc Gynecol; 2010 Aug; 23(4):209-14. PubMed ID: 20471875
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers M, Levy B, Nichols S.
    Fertil Steril; 2006 Nov; 86(5):1466-74. PubMed ID: 16996507
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.
    Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR.
    Contraception; 2006 Aug; 74(2):90-9. PubMed ID: 16860045
    [Abstract] [Full Text] [Related]

  • 12. Bone mineral density in adolescent females using depot medroxyprogesterone acetate.
    Lara-Torre E, Edwards CP, Perlman S, Hertweck SP.
    J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):17-21. PubMed ID: 15010034
    [Abstract] [Full Text] [Related]

  • 13. Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%.
    Harel Z, Wolter K, Gold MA, Cromer B, Stager M, Johnson CC, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Burkman R, Nelson A, Marshall S, Bachrach LK.
    Contraception; 2010 Dec; 82(6):503-12. PubMed ID: 21074012
    [Abstract] [Full Text] [Related]

  • 14. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women.
    Zhang MH, Zhang W, Zhang AD, Yang Y, Gai L.
    Chin Med J (Engl); 2013 Nov; 126(21):4043-7. PubMed ID: 24229671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM.
    J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate.
    Pitts SA, Feldman HA, Dorale A, Gordon CM.
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):23-6. PubMed ID: 22078997
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.